***Meeting program subject to change.
        
        Available Formats:      = Livestream 
  = In Person   
  = On Demand
      
       
      
      
        
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          4:00–8:00 PM
        
        
           3rd Floor Foyer
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          6:00–8:00 PM
        
        
           3rd Floor Foyer
        
        
        
         
        
              
      
    
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:00–8:00 AM
        
        
           Summit Gallery
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Welcome and Keynote Address (Joint)
          
          
         
              
              
              
        
          8:00–9:00 AM
        
        
           Breckenridge Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Alexandra Trkola, University of Zürich
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
          
            Immune Interventions Interfacing HIV Prevention and Cure (Joint)
          
          
         
              
              
              
        
          9:00–11:15 AM
        
        
           Breckenridge Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Mauricio A. Martins, University of Florida
Promoting Persistent bNAb Expression in NHPs through AAV-Mediated Gene Transfer
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Devi SenGupta, Gilead Sciences, Inc.
Long-acting ART in HIV Prevention and Cure
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Leonidas Stamatatos, Fred Hutchinson Cancer Research Center
Vaccination of PLWH, using 426C Derived Immunogens
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talk(s) Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          9:30–9:50 AM
        
        
           1st Floor Foyer
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Award Recipient Acknowledgement
          
          
         
              
              
              
        
          9:50–9:55 AM
        
        
           Breckenridge Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          11:15–1:00 PM
        
        
           Peaks 1 - 3
        
        
        
         
        
              
      
    
      
           
      
  
        
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          1:00–10:00 PM
        
        
           Peaks 1 - 3
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
          
          
         
              
              
              
        
          2:30–4:30 PM
        
        
           Colorado Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talks Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          4:30–5:00 PM
        
        
           3rd Floor Foyer
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Keeping up with the Changing HIV Envelope
          
          
         
              
              
              
        
          5:00–7:00 PM
        
        
           Colorado Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Penny L Moore, University of the Witwatersrand and National Institute for Communicable Diseases
African bNAb Immunogens
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Margaret E. Ackerman, Dartmouth College
Fc Effector Function in HIV Infection and Vaccination
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Aime Marcel Simon Tongo Passo, Center for Research on Emerging and Re-Emerging Diseases (CREMER/IMPM)
Viral Diversity in Central Africa: Known and Unknowns
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talk(s) Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:00–8:00 PM
        
        
           Summit Gallery
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:30–10:00 PM
        
        
           Peaks 1 - 3
        
        
        
         
        
              
      
    
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:00–8:00 AM
        
        
           Summit Gallery
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            The Vaccine Pipeline: Integrating Basic and Clinical Insights
          
          
         
              
              
              
        
          8:00–11:00 AM
        
        
           Colorado Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Richard T. Wyatt, The Scripps Research Institute
Triggering bNAbs in Non-Human Primates
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Persephone Borrow, University of Oxford
Creating an Immune Environment Favorable for HIV-1 bnAb Induction
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Louis J. Picker, Oregon Health & Science University
Progress in CMV based Vaccines
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talk(s) Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          9:00–9:20 AM
        
        
           3rd Floor Foyer
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          11:00–1:00 PM
        
        
           Peaks 1 - 3
        
        
        
         
        
              
      
    
      
           
      
  
        
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          1:00–10:00 PM
        
        
           Peaks 1 - 3
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Panel: Perspectives: Personalized Medicine & Patient-Centered Strategies (Joint)
          
          
         
              
              
              
        
          1:30–2:45 PM
        
        
           Breckenridge Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Career Roundtable (Joint)
          
          
         
              
              
              
        
          3:00–4:30 PM
        
        
           Breckenridge Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          4:30–5:00 PM
        
        
           3rd Floor Foyer
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Targeting the Needle in the Haystack: Clinical Trials of Germline Targeting Immunogens
          
          
         
              
              
              
        
          5:00–7:00 PM
        
        
           Colorado Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Kevin O. Saunders, Duke University
Induction of HCDR3-Binding and CD4 Mimicking Antibodies in HVTN300 and HVTN309
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Eunice Wambui Nduati, KEMRI, Wellcome Trust
Germline Targeting Immunogens and Precursors in African Populations
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Marit van Gils, Amsterdam UMC
Germline Targeting Immunogens in Human Clinical Trials; C101, C107, C110
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talk(s) Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:00–8:00 PM
        
        
           Summit Gallery
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:30–10:00 PM
        
        
           Peaks 1 - 3
        
        
        
         
        
              
      
    
      
        
          
           
      
  
      
        
      
  
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:00–8:00 AM
        
        
           Summit Gallery
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            Looking to the Future: New Tools,  Platforms and Delivery Systems
          
          
         
              
              
              
        
          8:00–11:00 AM
        
        
           Colorado Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Eric A. Appel, Stanford University
Injectable Hydrogel Depot Technologies for Sustained Delivery of Vaccines
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Shannon Miller, Inimmune Corporation
Adjuvants for Mucosal Immunity
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Rory Henderson, Duke University
Large Language Models to Identify bnAbs and Design Vaccines to Them
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talk(s) Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          9:00–9:20 AM
        
        
           3rd Floor Foyer
        
        
        
         
        
              
      
    
      
           
      
  
        
        
              
      
    
      
           
      
  
      
        
        
        
          
            Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
          
          
         
              
              
              
        
          2:30–4:30 PM
        
        
           Colorado Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talks Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          4:30–5:00 PM
        
        
           1st Floor Foyer
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
          
            B Cell Responses and Broadly-Neutralizing Antibodies: Trials and Tribulations (Joint)
          
          
         
              
              
              
        
          5:00–6:45 PM
        
        
           Breckenridge Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Marina F. Caskey, Rockefeller University
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Paula M. Cannon, University of Southern California, Keck School of Medicine
Engineering B Cells as in vivo bnAb Factories
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          William Schief, The Scripps Research and IAVI
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
        
        
       
        
              
      
    
      
           
      
  
      
        
      
  
        
      
     
      
        
        
          Short Talk(s) Chosen from Abstracts
        
        
       
        
              
      
    
      
           
      
  
      
        
        
        
          
            Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
          
          
         
              
              
              
        
          6:45–7:00 PM
        
        
           Breckenridge Ballroom
        
        
        
         
        
              
      
    
      
           
      
  
      
        
        
        
              
              
              
        
          7:00–8:00 PM
        
        
           Summit Gallery